Dorsomorphin

Cat. No.: OB0225LY-0195

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, HPLC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Product Overview

Description: Dorsomorphin is a small molecule compound that acts primarily as an antagonist of the BMP (bone morphogenetic protein) signaling pathway. It affects cell proliferation and differentiation by inhibiting the Smad signaling pathway.

Synonym: BML-275; 866405-64-3; 6-(4-(2-(Piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine; 4-(6-{4-[2-(Piperidin-1-yl)ethoxy]phenyl}pyrazolo[1,5-a]pyrimidin-3-yl)pyridine; 6-(4-(2-(1-Piperidinyl)ethoxy)phenyl)-3-(4-pyridinyl)pyrazolo(1,5-a)pyrimidine; 4-(6-(4-(2-(Piperidin-1-yl)ethoxy)phenyl)pyrazolo(1,5-a)pyrimidin-3-yl)pyridine; Pyrazolo(1,5-a)pyrimidine, 6-(4-(2-(1-piperidinyl)ethoxy)phenyl)-3-(4-pyridinyl)-

CAS No.: 866405-64-3

Compound CID: 11524144

Formula: C₂₄H₂₅N₅O

Formula Weight: 399.49

Specification

Relative Density: 1.255 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Dorsomorphin can be used to study the regulatory mechanisms of the BMP signaling pathway or play an important role in stem cell differentiation and bone regeneration studies.